Group 1: Company Overview - The company specializes in the R&D, production, and sales of high-definition and ultra-high-definition video conferencing cameras, video conferencing terminals, and related audio-visual communication equipment [1] - It is a major supplier of audio-visual communication equipment and solutions in China, with applications in business video conferencing, education recording, remote education, remote medical care, and more [1] Group 2: Industry Trends and Growth Drivers - The video conferencing camera industry is expected to evolve around technological upgrades, diversified applications, and innovative service models driven by technological innovation and demand upgrades [2] - Future growth is primarily driven by three factors: 1. Technological iteration, with AI and 5G integration enhancing features like smart framing and real-time translation, and H.266 codec technology reducing bandwidth requirements by 50% [2] 2. The normalization of hybrid work, leading to a polarization in hardware development towards consumer-grade portable devices and high-end all-in-one machines [2] 3. Global expansion through overseas production capacity and marketing network development to capture market share [2] Group 3: Product and Market Expansion - The company plans to expand into more niche application areas while enhancing its product matrix's vertical scene adaptability and horizontal ecological synergy through technological innovation [2] - In 2025, the company aims to strengthen local marketing teams and optimize channel management to enhance global market influence and brand recognition [3] Group 4: Supply Chain and Profitability - The company is focused on optimizing its supply chain by advancing equipment automation and digital system collaboration to enhance production efficiency [3] - Future gross margin is expected to be maintained through product innovation, customer structure optimization, and exploring high-value markets [3] Group 5: Mergers and Acquisitions Strategy - The company is actively seeking quality targets for mergers and acquisitions, focusing on "technology-driven + ecological synergy" strategies to deepen its core technology fields [3] - It aims to enhance competitive advantages in key areas of the industry chain and accelerate technology integration and market complementarity through strategic collaborations [3]

证券代码：301318 证券简称：维海德 公告编号：2025-026 深圳市维海德技术股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、深圳市维海德技术股份有限公司（以下简称"公司"）回购专用证券账户 中的股份265,591股不参与本次权益分派。本次权益分派将以公司现有总股本 135,130,876股剔除已回购股份265,591股后的134,865,285股为基数，向全体股东每 10股派3.75元人民币（含税），实际派发现金分红总额=134,865,285股×3.75元/10 股=50,574,481.88元（含税）。 2、本次权益分派实施后，按公司总股本135,130,876股折算的每10股现金分红 金额以及据此计算的除权除息参考价的相关参数和公式计算如下：按公司总股本 （含回购股份）折算的每10股现金分红金额（含税）=本次实际现金分红总额/公 司总股本×10股=50,574,481.88元÷135,130,876股×10股=3.742629 元（保留六位 小数，最后一位直接截取，不四舍五入）；本 ...

Group 1 - Hongjing Technology signed a service contract for an intelligent computing project with a total amount of 597 million yuan, valid for 5 years [1] - Weifu High-Tech's subsidiary invested 220 million yuan to establish a joint venture with Shanghai Baolong Automotive Technology [2] - Zhongshan Public received approval for the registration of short-term financing bonds amounting to 2 billion yuan and medium-term notes of 3 billion yuan [3] Group 2 - Lianhua Technology established a venture capital fund with a total commitment of 200 million yuan, contributing 100 million yuan as a limited partner [4] - Changan Technology's shareholder signed an agreement to transfer 6.27% of the company's shares to Hefei State Capital Venture Investment [6] - Hangzhou Garden announced a cash dividend of 0.5 yuan per 10 shares, totaling 6.62 million yuan [8] Group 3 - Huamao Technology plans to acquire 100% equity of Fuchuang Youyue, leading to a temporary suspension of its stock [9] - Zhuojin Co. won a bid for a soil remediation project in Hefei with a contract value of 67.68 million yuan [10] - Shanghai Pharmaceuticals received FDA approval for two drugs, enhancing its product portfolio [10] Group 4 - Fuxing Pharmaceutical's senior vice president resigned for personal reasons [12] - Baolong Technology's subsidiary plans to invest 180 million yuan in a joint venture [13] - ST Zhongdi intends to utilize surplus funds from a project company, with a maximum of 106 million yuan [14] Group 5 - Nanchao Food reported a significant decline in net profit for April, down 82.14% year-on-year [16] - Changshan Pharmaceutical received a drug registration certificate in Belarus for a new product [18] - Nanshan Aluminum established a wholly-owned subsidiary for photovoltaic energy projects with an investment of 5 million yuan [20] Group 6 - Bozhong Precision announced the resignation of a director and deputy general manager [22] - Xinjiang Jiaojian won a bid for a highway construction project valued at 451 million yuan [23] - Guangzhou Restaurant declared a cash dividend of 0.48 yuan per share, totaling 273 million yuan [25] Group 7 - Weili Medical's subsidiary obtained a medical device operating license, allowing it to engage in wholesale activities [27] - New Australia Co. announced a cash dividend of 0.3 yuan per share, totaling 219 million yuan [28] - Lianhua Technology's subsidiary entered the new third board innovation layer [29] Group 8 - Huaxi Energy's chairman resigned due to personal reasons [31] - Yipin Hong plans to use up to 500 million yuan of idle funds for cash management [33] - Shouhua Gas intends to purchase bauxite resources through market means [34] Group 9 - Jincheng signed a service agreement for underground mining operations at the Komakau Copper Mine, valued at approximately 805 million USD [34] - Wanrun New Energy signed a supply contract with CATL for lithium iron phosphate products, with a total supply of about 1.32 million tons [35] - Weili plans to transfer 100% equity of a subsidiary to Chengfa Environment for 100 million yuan [36] Group 10 - Zhenlei Technology's subsidiary received government subsidies of 2.21 million yuan, positively impacting profits [38] - Weir shares plan to change their name to "Haowei Group" to reflect strategic direction [39] - YTO Express reported a revenue increase of 16.32% in April, totaling 5.755 billion yuan [39]

Core Viewpoint - The company Weihaide (301318.SZ) announced a share reduction plan by major shareholders, which includes a total reduction of 2,487,500 shares, accounting for 1.84% of the company's total share capital [1][2][3]. Shareholder Reduction Plans - Major shareholder Wang Yan holds 16,846,050 shares (12.49% of total shares) and plans to reduce up to 800,000 shares (0.59%) from June 11, 2025, to September 10, 2025 [1][3]. - Director and Vice President Chen Liwu holds 3,775,200 shares (2.80%) and plans to reduce up to 900,000 shares (0.67%) during the same period [1][2]. - Vice President Lü Jialong holds 1,950,000 shares (1.45%) and plans to reduce up to 487,500 shares (0.36%) [2][3]. - Financial Director Wu Wenjuan holds 1,209,000 shares (0.90%) and plans to reduce up to 300,000 shares (0.22%) [2][3]. - The total planned reduction by these shareholders amounts to 2,487,500 shares, representing 1.84% of the company's total share capital [2][3]. Company Background - Weihaide was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on August 10, 2022, with an initial public offering of 17.36 million shares at a price of 64.68 yuan per share [4]. - The company is currently in a state of share price decline, having fallen below its initial offering price [4]. Fundraising and Projects - Weihaide raised a total of 1.1228448 billion yuan in its public offering, with a net amount of 1.0448897 billion yuan after deducting issuance costs [5]. - The original fundraising target was 490.6798 million yuan for projects including the industrial expansion of audio and video communication equipment, R&D center construction, marketing network development, and working capital [5][6]. Dividend Announcements - The company announced a dividend plan on May 20, 2023, proposing a bonus of 5 shares for every 10 shares held and a pre-tax dividend of 3 yuan, with the record date on May 26, 2023 [7]. - A subsequent dividend announcement for May 18, 2024, includes a proposal for a bonus of 3 shares for every 10 shares held and a pre-tax dividend of 2 yuan, with the record date on May 23, 2024 [7].

证券代码：301318 证券简称：维海德 公告编号：2025-025 深圳市维海德技术股份有限公司 关于公司董事、高级管理人员及持股 5%以上股东减持股份 的预披露公告 公司持股 5%以上股东王艳、董事兼副总经理陈立武、副总经理吕家龙、财 务总监吴文娟保证向本公司提供的信息内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 公司财务总监吴文娟，现持有公司股份 1,209,000 股，占公司总股本的 0.90%， 计划在本减持计划公告披露之日起 15 个交易日后的三个月内（自 2025 年 6 月 11 日至 2025 年 9 月 10 日）以集中竞价或大宗交易方式减持公司股份不超过 300,000 股（占公司总股本的 0.22%）。 深圳市维海德技术股份有限公司（以下简称"公司"）于近日收到公司持股 5%以上股东王艳、董事兼副总经理陈立武、副总经理吕家龙、财务总监吴文娟 出具的《关于股份减持计划的告知函》，现将有关情况公告如下： 注：持股 5%以上股东王艳是公司现任董事、副总经理史立庆的配偶，王艳承诺"在本 人配偶史立庆任职期间内，每年转让的股份不超过上一年末所直接和间接持有的公司股份总 数的 25 ...

证券代码：301318 证券简称：维海德 公告编号：2025-024 深圳市维海德技术股份有限公司 关于变更持续督导保荐代表人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市维海德技术股份有限公司董事会 2025 年 5 月 16 日 附件：黄松先生的简历 深圳市维海德技术股份有限公司（以下简称"公司"）于近日收到方正证券 承销保荐有限责任公司（以下简称"方正承销保荐"）出具的《关于更换持续督 导保荐代表人的函》。方正承销保荐作为公司首次公开发行股票并在创业板上市 项目的保荐机构和主承销商，原委派保荐代表人郭文杰先生和李廷春先生负责公 司的持续督导工作。现保荐代表人李廷春先生因工作调整，将不再担任公司持续 督导的保荐代表人。为保证持续督导工作的有序进行，方正承销保荐委派保荐代 表人黄松先生（简历详见附件）接替李廷春先生继续履行持续督导职责。 本次变更后，公司首次公开发行股票并在创业板上市的持续督导保荐代表人 为郭文杰先生和黄松先生，持续督导期至中国证券监督管理委员会和深圳证券 交易所规定的持续督导义务结束为止。 公司董事会对李廷春先生在持续督导期 ...

证券代码：301318 证券简称：维海德 公告编号：2025-023 2. 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1.现场会议召开时间：2025年5月15日（星期四）下午14:30 2.会议召集人：公司董事会 深圳市维海德技术股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东大会未出现否决提案的情形。 4.现场会议召开地点：深圳市宝安区新安街道鸿辉工业园2栋3楼公司会议室 5.网络投票时间： （1）通过深圳证券交易所交易系统进行网络投票的具体时间为2025年5月15 日的交易时间，即9:15—9:25，9:30—11:30和13:00—15:00； （2）通过深圳证券交易所互联网投票系统进行网络投票的开始时间为2025 年5月15日上午9:15—下午15:00期间的任意时间。 6.召开方式：现场会议与网络投票相结合的方式 7.本次股东大会的召集和召开符合《公司法》、《上市公司股东会规则》等 有关法律、行政法规、部门规章、规范性文件和《公司章程》的有关规定。 ...

北京德恒（深圳）律师事务所 关于深圳市维海德技术股份有限公司 2024 年年度股东大会的 法律意见 2024 年年度股东大会的 法律意见 德恒 06G20250115-01 号 致：深圳市维海德技术股份有限公司 深圳市维海德技术股份有限公司（以下简称公司）2024 年年度股东大会（以 下简称本次会议）于 2025 年 5 月 15 日（星期四）召开。北京德恒（深圳）律师 事务所（以下简称德恒）受公司委托，指派王琪瑶律师、周子锋律师（以下简称 德恒律师）出席了本次会议。根据《中华人民共和国证券法》（以下简称《证券 法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券监督管 理委员会《上市公司股东会规则》（以下简称《股东会规则》）等法律、行政法 规、部门规章、规范性文件和《深圳市维海德技术股份有限公司章程》（以下简 称《公司章程》）的规定，德恒律师就本次会议的召集、召开程序、现场出席会 议人员资格、表决程序、表决结果等相关事项进行见证，并发表法律意见。 深圳市福田区金田路 4018 号安联大厦 B 座 11 层 电话：0755-88286488 传真：0755-88286499 邮编：518038 北 ...

2024年度跟踪报告 | 保荐人名称：方正证券承销保荐有限责任公司 | 被保荐公司简称：维海德（301318） | | --- | --- | | 保荐代表人姓名：李廷春 | 联系电话：0755-36876275 | | 保荐代表人姓名：郭文杰 | 联系电话：0755-36876275 | 方正证券承销保荐有限责任公司 关于深圳市维海德技术股份有限公司 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0次 | | 2．督导公司建立健全并有效执行规章制度的情 | | | 况 | | | （1）是否督导公司建立健全规章制度（包括 但不限于防止关联方占用公司资源的制度、募 | | | | 是 | | 集资金管理制度、内控制度、内部审计制度、关 | | | 联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 12次 | | （2）公司募集资金项目进展是否与信息披 ...

| 保荐人名称：方正证券承销保荐有限责任公司 被保荐公司简称：维海德（301318） | | | | --- | --- | --- | | 保荐代表人姓名：李廷春 联系电话：0755-36876275 | | | | 保荐代表人姓名：郭文杰 联系电话：0755-36876275 | | | | 现场检查人员姓名：李廷春、郭文杰 | | | | 现场检查对应期间：2024 年度 | | | | 现场检查时间：2025 年 4 月 7 日至 4 月 30 日 | | | | 一、现场检查事项 现场检查意见 | | | | （一）公司治理 否 | 是 | 不适用 | | 现场检查手段：查阅公司章程、三会会议相关文件、公告等；访谈公司相关人员，了解公 | | | | 司章程和公司治理制度是否完备、合规等；察看公司主要经营、管理场所。 | | | | 1.公司章程和公司治理制度是否完备、合规 | √ | | | 2.公司章程和股东会、董事会规则是否得到有效执行 | √ | | | 3.股东会、董事会会议记录是否完整，时间、地点、出席人员 | √ | | | 及会议内容等要件是否齐备，会议资料是否保存完整 | | | ...